688639.SH
Anhui Huaheng Biotechnology Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 15.95
−1.30%Oct 13, 2026, 07:52 UTC
Huaheng Biotechnology said its remuneration and assessment committee verified that the initial recipients under its 2026 restricted-stock incentive plan met the eligibility requirements, and the company’s internal notice period ended without objections.
Source:Jul 31, 2026, 11:13 UTC
Huaheng Biology's actual controller Guo Henghua was approved for arrest by the procuratorate on suspicion of illegally absorbing public deposits; the company received notice from her family on July 31, 2026.
Source:Jul 2, 2026, 17:39 UTC
Huafeng Biology terminated its H-share listing plan on the Hong Kong Stock Exchange after Guo Henghua's detention.
Source:Jul 2, 2026, 17:39 UTC
Guo Henghua resigned from all positions including chairman and general manager of Huafeng Biology following her criminal detention.
Source: